Matthias Eiber - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Matthias Eiber

Showing results (161-170 of 377) with videos related to

Pageof 38

Sort By:

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 9, 2017

PSMA Ligands for PET Imaging of Prostate CancerSarah M Schwarzenboeck, Isabel Rauscher, Christina Bluemel, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2020

PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center StudyManuel Weber, Claudia Kurek, Francesco Barbato, et al.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 11, 2021

In silico study on radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapyGabriele Birindelli, Milos Drobnjakovic, Volker Morath, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2016

Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage LymphadenectomyIsabel Rauscher, Tobias Maurer, Ambros J Beer, et al.

European Journal of Nuclear Medicine and Molecular Imaging|January 23, 2025

Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancerAmir Karimzadeh, Kimberley Hansen, Ergela Hasa, et al.

Minerva Urology and Nephrology|December 21, 2023

Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancerFrancesca Ambrosini, Fabian Falkenbach, Lars Budaeus, et al.

Cancers|October 28, 2023

EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate CancerFabian Falkenbach, Francesca Ambrosini, Pierre Tennstedt, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023

The Impact of PSMA PET-Based Eligibility Criteria Used in the Prospective Phase II TheraP Trial in Metastatic Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen-Targeted Radioligand TherapyAmir Karimzadeh, Matthias Heck, Robert Tauber, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2018

68Ga-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET ImagingChristoph Rischpler, Teresa I Beck, Shozo Okamoto, et al.

EJNMMI Radiopharmacy and Chemistry|January 23, 2021

Automated synthesis of [18F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productionsAlexander Wurzer, Daniel Di Carlo, Michael Herz, et al.

Pageof 38

Search research articles

Showing results (161-170 of 377) with videos related to

Sort By:

Pageof 38

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 9, 2017

PSMA Ligands for PET Imaging of Prostate CancerSarah M Schwarzenboeck, Isabel Rauscher, Christina Bluemel, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 24, 2020

PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center StudyManuel Weber, Claudia Kurek, Francesco Barbato, et al.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|December 11, 2021

In silico study on radiobiological efficacy of Ac-225 and Lu-177 for PSMA-guided radiotherapyGabriele Birindelli, Milos Drobnjakovic, Volker Morath, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2016

European Journal of Nuclear Medicine and Molecular Imaging|January 23, 2025

Minerva Urology and Nephrology|December 21, 2023

Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancerFrancesca Ambrosini, Fabian Falkenbach, Lars Budaeus, et al.

Cancers|October 28, 2023

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 8, 2023

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2018

68Ga-PSMA-HBED-CC Uptake in Cervical, Celiac, and Sacral Ganglia as an Important Pitfall in Prostate Cancer PET ImagingChristoph Rischpler, Teresa I Beck, Shozo Okamoto, et al.

EJNMMI Radiopharmacy and Chemistry|January 23, 2021

Automated synthesis of [18F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productionsAlexander Wurzer, Daniel Di Carlo, Michael Herz, et al.

Pageof 38